Moreover, the adoptive transfer of Il1r8−/− NK cells provided sufficient protection in the metastasis models suggesting that blockade of IL-1R8 may represent a therapeutic approach to enhance NK cell activity and promote anti-tumour activity in the clinic [97]. This evidence concerns the gene SIGIRR and neoplasm.